Matches in Wikidata for { <http://www.wikidata.org/entity/Q85312875> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q85312875 description "article scientifique publié en 2012" @default.
- Q85312875 description "artículu científicu espublizáu n'ochobre de 2012" @default.
- Q85312875 description "scientific article published on 29 October 2012" @default.
- Q85312875 description "wetenschappelijk artikel" @default.
- Q85312875 description "наукова стаття, опублікована в жовтні 2012" @default.
- Q85312875 name "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 name "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 type Item @default.
- Q85312875 label "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 label "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 prefLabel "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 prefLabel "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 P1433 Q85312875-111274A3-C53B-424B-980B-26563549F366 @default.
- Q85312875 P1476 Q85312875-4BC4269D-6A6C-4CFC-9F46-CB64E7CEDCC4 @default.
- Q85312875 P2093 Q85312875-093C0E9F-CE01-486F-9DC9-AD4609E186B0 @default.
- Q85312875 P2093 Q85312875-5D9827A8-8429-4857-928B-4C0BD6A1A2B6 @default.
- Q85312875 P2093 Q85312875-805DC23F-64AB-4463-B623-169C186567FE @default.
- Q85312875 P2093 Q85312875-840E16C3-E43A-4E9F-882D-2338085F2341 @default.
- Q85312875 P2093 Q85312875-8AFA97C6-0417-4833-8FC4-17FE24CE2019 @default.
- Q85312875 P2093 Q85312875-91CD4B3B-034A-4A27-B8C7-95FBFBBA9D00 @default.
- Q85312875 P2093 Q85312875-B39819CF-4AAA-4F93-9F38-09DABFFF7EE5 @default.
- Q85312875 P2093 Q85312875-C0F967F5-87E4-4D3C-B081-6162612F8890 @default.
- Q85312875 P2093 Q85312875-C8BB247F-BA74-48DF-97DC-C09697EF37C6 @default.
- Q85312875 P304 Q85312875-E423E763-C13B-4819-B000-CD2394895527 @default.
- Q85312875 P31 Q85312875-23F5DF7B-7A3A-459A-80D2-5DD68886CA84 @default.
- Q85312875 P356 Q85312875-E4336758-D4FA-4FF4-ABA6-751FAC811933 @default.
- Q85312875 P433 Q85312875-4489088E-9EE5-4144-9479-32E5146565DE @default.
- Q85312875 P478 Q85312875-7DD15274-CEFF-4D20-9330-312D861A92FE @default.
- Q85312875 P50 Q85312875-74962043-741C-4862-924A-E688842881ED @default.
- Q85312875 P577 Q85312875-B67BCE34-AD4E-4B08-83E9-1277AC3F8DF7 @default.
- Q85312875 P698 Q85312875-A31F77BF-ED4D-42FB-9E0A-5731C9B13EF1 @default.
- Q85312875 P921 Q85312875-46E1D6CC-17A8-4567-9556-083E0BF369C1 @default.
- Q85312875 P921 Q85312875-E80D5327-97D1-4C1F-B8C2-BFC18BEFE4D6 @default.
- Q85312875 P921 Q85312875-ED361408-5CA4-444F-AAAC-02C72BE68405 @default.
- Q85312875 P356 JCO.2011.40.5712 @default.
- Q85312875 P698 23109694 @default.
- Q85312875 P1433 Q400292 @default.
- Q85312875 P1476 "Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study" @default.
- Q85312875 P2093 "Alain Landau" @default.
- Q85312875 P2093 "Daniela Lebrun-Jezekova" @default.
- Q85312875 P2093 "Didier Mayeur" @default.
- Q85312875 P2093 "Estelle Botton" @default.
- Q85312875 P2093 "Joëlle Blumberg" @default.
- Q85312875 P2093 "Laure Chauvenet" @default.
- Q85312875 P2093 "Olivier Beatrix" @default.
- Q85312875 P2093 "Pascale Mariani" @default.
- Q85312875 P2093 "Robert Herve" @default.
- Q85312875 P304 "4337-4343" @default.
- Q85312875 P31 Q13442814 @default.
- Q85312875 P356 "10.1200/JCO.2011.40.5712" @default.
- Q85312875 P433 "35" @default.
- Q85312875 P478 "30" @default.
- Q85312875 P50 Q97092274 @default.
- Q85312875 P577 "2012-10-29T00:00:00Z" @default.
- Q85312875 P698 "23109694" @default.
- Q85312875 P921 Q16244733 @default.
- Q85312875 P921 Q2071182 @default.
- Q85312875 P921 Q269829 @default.